In our Expert Video Series: Life Sciences M&A Study, we present key findings and trends within our 2019 Life Sciences M&A Study featuring Don Morrissey, Head of Life Sciences, Christopher Letang, Managing Director, and Ann Byers, Director.
The study analyzes 227 life sciences M&A transactions since 2008, involving biotech/pharmaceutical products, medical devices, diagnostics, and life sciences tools and technologies, in which SRS Acquiom provided professional and financial services. Additionally, from over 160 life sciences deals that have earnouts, we present milestone achievement data and experience from 131 transactions that have been closed more than one year and have significant post-closing experience, including: over 725 individual milestones; over $30B in potential defined earnout/milestone payments (plus uncapped payments, royalties, etc.); and over 425 individual milestones (over $13B potential) originally expected to be hit or missed by May 2019.
Unique data points covered in this video series include:
- Milestone Achievement Trends
- Value of Earnout Milestones
- Importance of Milestones
Download the full 2019 Life Sciences M&A Study
Milestone Achievement Trends (2:06)
Value of Earnout Milestones (1:31)
Importance of Milestones (2:03)